Shenzhen Bioeasy (China) Probability of Future Stock Price Finishing Under 8.92
300942 Stock | 9.88 0.74 6.97% |
Shenzhen |
Shenzhen Bioeasy Target Price Odds to finish below 8.92
The tendency of Shenzhen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current Price | Horizon | Target Price | Odds to drop to 8.92 or more in 90 days |
9.88 | 90 days | 8.92 | about 79.38 |
Based on a normal probability distribution, the odds of Shenzhen Bioeasy to drop to 8.92 or more in 90 days from now is about 79.38 (This Shenzhen Bioeasy Biotechnology probability density function shows the probability of Shenzhen Stock to fall within a particular range of prices over 90 days) . Probability of Shenzhen Bioeasy Bio price to stay between 8.92 and its current price of 9.88 at the end of the 90-day period is about 15.02 .
Assuming the 90 days trading horizon Shenzhen Bioeasy has a beta of 0.52. This suggests as returns on the market go up, Shenzhen Bioeasy average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Shenzhen Bioeasy Biotechnology will be expected to be much smaller as well. Additionally Shenzhen Bioeasy Biotechnology has an alpha of 0.6388, implying that it can generate a 0.64 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Shenzhen Bioeasy Price Density |
Price |
Predictive Modules for Shenzhen Bioeasy
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Shenzhen Bioeasy Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Shenzhen Bioeasy Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Shenzhen Bioeasy is not an exception. The market had few large corrections towards the Shenzhen Bioeasy's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Shenzhen Bioeasy Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Shenzhen Bioeasy within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.64 | |
β | Beta against Dow Jones | 0.52 | |
σ | Overall volatility | 1.24 | |
Ir | Information ratio | 0.12 |
Shenzhen Bioeasy Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Shenzhen Bioeasy for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Shenzhen Bioeasy Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.Shenzhen Bioeasy Bio appears to be risky and price may revert if volatility continues | |
The company reported the revenue of 254.11 M. Net Loss for the year was (184.91 M) with profit before overhead, payroll, taxes, and interest of 428.03 M. | |
Shenzhen Bioeasy generates negative cash flow from operations | |
About 75.0% of the company shares are owned by insiders or employees | |
Latest headline from news.google.com: Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com |
Shenzhen Bioeasy Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Shenzhen Stock often depends not only on the future outlook of the current and potential Shenzhen Bioeasy's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Shenzhen Bioeasy's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 400.9 M |
Shenzhen Bioeasy Technical Analysis
Shenzhen Bioeasy's future price can be derived by breaking down and analyzing its technical indicators over time. Shenzhen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Shenzhen Bioeasy Biotechnology. In general, you should focus on analyzing Shenzhen Stock price patterns and their correlations with different microeconomic environments and drivers.
Shenzhen Bioeasy Predictive Forecast Models
Shenzhen Bioeasy's time-series forecasting models is one of many Shenzhen Bioeasy's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Shenzhen Bioeasy's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Shenzhen Bioeasy Bio
Checking the ongoing alerts about Shenzhen Bioeasy for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Shenzhen Bioeasy Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Shenzhen Bioeasy Bio appears to be risky and price may revert if volatility continues | |
The company reported the revenue of 254.11 M. Net Loss for the year was (184.91 M) with profit before overhead, payroll, taxes, and interest of 428.03 M. | |
Shenzhen Bioeasy generates negative cash flow from operations | |
About 75.0% of the company shares are owned by insiders or employees | |
Latest headline from news.google.com: Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com |
Other Information on Investing in Shenzhen Stock
Shenzhen Bioeasy financial ratios help investors to determine whether Shenzhen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenzhen with respect to the benefits of owning Shenzhen Bioeasy security.